E.C. Faulkner

Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group

E.C. Faulkner, Lieven Annemans, L. Garrison et al. · Value in Health · 2012 · 151 citations · Full text

Manufacturer Perspectives, Personalized Medicine—payer, Healthcare Value +15

Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group

E.C. Faulkner, Anke‐Peggy Holtorf, Surrey M. Walton et al. · Value in Health · 2020 · 108 citations · Full text

Medical Ethics, Health Policy, Address Precision Medicine +9

Solution Behavior of IFN-β-1a: An Empirical Phase Diagram Based Approach

Haihong Fan, John P. Ralston, Mary Dibiase et al. · Journal of Pharmaceutical Sciences · 2005 · 58 citations

Chemical Kinetics, Engineering, Physics +8

Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group

Susan Garfield, Julie Polisena, Daryl S. Spinner et al. · Value in Health · 2016 · 42 citations

Point-of-care Testing, Engineering, Clinical Laboratory Technologies +14

Expression-Based Discovery of Variation in the Human Glutathione <i>S</i>-Transferase M3 Promoter and Functional Analysis in a Glioma Cell Line Using Allele-Specific Chromatin Immunoprecipitation

Xuemei Liu, Michelle R. Campbell, Gary S. Pittman et al. · Cancer Research · 2005 · 41 citations · Full text

Engineering, Genetics, Human Polymorphism +19